Low Volume High Intensity Interval Training in Operated Lung Cancer Patients
Comparison of the Effects of Continuous Aerobic Exercise Training and Low Volume High Intensity Interval Training on Cardiopulmonary Exercise Capacity, Autonomic Function and Oxidative Stress in Operated Lung Cancer Patients
1 other identifier
interventional
40
1 country
1
Brief Summary
Patients included in the study will be randomly divided into 2 groups using appropriate randomization programs. All patients will be given exercise training individually for 24 sessions using a bicycle ergometer under the supervision of a physiotherapist.Patients in the first group will be given exercise training on a bicycle ergometer for 5 minutes warm-up phase at 40% of maximal oxygen consumption (VO2max), 20 minutes exercise phase at 60% of VO2max and 5 minutes cool down phase at 40% of VO2max for a total of 30 minutes. Patients in the second group will be given a warm-up phase for 3 minutes at 50% VO2max, 1 minute at 80-100% VO2max and 1 minute at 50% VO2max in 10 cycles, and finally a cool-down phase for 3 minutes at 50% VO2max. In total, 25 minutes of low-volume high-intensity intermittent exercise training will be given on a bicycle ergometer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable lung-cancer
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 6, 2023
CompletedFirst Submitted
Initial submission to the registry
April 15, 2023
CompletedFirst Posted
Study publicly available on registry
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 6, 2025
CompletedJuly 18, 2024
July 1, 2024
2 years
April 15, 2023
July 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Maximal oxygen consumption
To be measured during cardiopulmonary exercise testing
24 months
Heart Rate Variability
To be measured during cardiopulmonary exercise testing
24 months
Oxidative Stress
Lipid peroxidation marker from serum for determination of oxidative damage melondialdehyde (MDA), total oxidant status (TOS), total antioxidant status (TAS) parameters will be evaluated.
24 months
Myokine
Irisin levels in serum, enzyme-linked immunosorbent assay (Enzyme-Linked Immuno Sorbent Assay-ELISA) method using a commercial kit.
24 months
Secondary Outcomes (3)
Change in quality of life
24 months
Peripheral Muscle Strength
24 months
Activity of Daily Living
24 months
Study Arms (2)
Low Volume High Intensity Exercise Training
EXPERIMENTALPatients in the intervention group will be given a warm-up phase for 3 minutes at 50% VO2max, 1 minute at 80-100% VO2max and 1 minute at 50% VO2max in 10 cycles, and finally a cool-down phase for 3 minutes at 50% VO2max.
Aerobic Exercise
ACTIVE COMPARATORPatients in the control group will be given exercise training on a bicycle ergometer for 5 minutes warm-up phase at 40% of maximal oxygen consumption (VO2max), 20 minutes exercise phase at 60% of VO2max and 5 minutes cool down phase at 40% of VO2max for a total of 30 minutes.
Interventions
Patients in the intervention group will be given a warm-up phase for 3 minutes at 50% VO2max, 1 minute at 80-100% VO2max and 1 minute at 50% VO2max in 10 cycles, and finally a cool-down phase for 3 minutes at 50% VO2max.
Patients in the control group will be given exercise training on a bicycle ergometer for 5 minutes warm-up phase at 40% of maximal oxygen consumption (VO2max), 20 minutes exercise phase at 60% of VO2max and 5 minutes cool down phase at 40% of VO2max for a total of 30 minutes.
Eligibility Criteria
You may qualify if:
- Diagnosed with Non-Small Cell Lung Cancer
- Stage 3A and earlier
- Operated and at least 6 months have expired since the surgery
- Having completed adjuvant treatments such as chemotherapy and radiotherapy and at least 6 months have expired
- Being clinically stable and in remission
- Not having new recurrence and active cancer
You may not qualify if:
- Pneumonectomy surgery
- Presence of symptoms, signs and diagnoses indicating the presence of lung and cardiac disease such as advanced COPD
- Having any orthopedic or neurological problem that may prevent exercise
- Presence of recurrence or active cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hacettepe Universitylead
- Ankara Universitycollaborator
Study Sites (1)
Ankara University
Ankara, Sıhhiye, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hamide Sahin-Yildiz, Msc,PT
Ankara University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, PT, Msc
Study Record Dates
First Submitted
April 15, 2023
First Posted
May 1, 2023
Study Start
April 6, 2023
Primary Completion
April 6, 2025
Study Completion
April 6, 2025
Last Updated
July 18, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share